OrbiMed’s Select Medical SEM Stock Holding History

OrbiMed’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,289,562	Closed	-$36.3M	–	162
2021 Q4	$36.3M	Sell	2,289,562 -69,600	-3%	-$1.19M	0.47%	60
2021 Q3	$46M	Hold	2,359,162	–	–	0.51%	55
2021 Q2	$53.7M	Buy	+2,359,162	New	+$49M	0.54%	56
2018 Q4	–	Sell	-1,920,424	Closed	-$19M	–	148
2018 Q3	$19M	Sell	1,920,424 -7,497,291	-80%	-$77.6M	0.23%	93
2018 Q2	$92.1M	Hold	9,417,715	–	–	1.1%	31
2018 Q1	$87.5M	Hold	9,417,715	–	–	1.09%	31
2017 Q4	$89.6M	Sell	9,417,715 -935,981	-9%	-$8.94M	1.13%	25
2017 Q3	$107M	Buy	10,353,696 +3,509,882	+51%	+$32.4M	1.02%	32
2017 Q2	$56.6M	Buy	6,843,814 +2,971,641	+77%	+$22.3M	0.59%	52
2017 Q1	$27.9M	Buy	3,872,173 +2,328,167	+151%	+$16.9M	0.32%	67
2016 Q4	$11M	Buy	+1,544,006	New	+$10.7M	0.14%	91

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

OrbiMed's SEM Position: Q1 2022 in Review

OrbiMed sold out of Select Medical (SEM) in Q1 2022, closing a stake of 2,289,562 shares — an estimated $36.3M sold.

OrbiMed first reported a position in SEM in Q4 2016 and held it in 11 quarters. The position peaked at $107M in Q3 2017. 240 funds tracked by Wall St. Rank hold SEM as of Q1 2022.

OrbiMed reported no remaining Select Medical position as of Q1 2022 after selling out during the quarter.
OrbiMed sold 2,289,562 Select Medical shares in Q1 2022, an estimated $36.3M.
OrbiMed first reported a position in Select Medical in Q4 2016 and held it in 11 quarters.
OrbiMed's Select Medical position peaked at $107M in Q3 2017.
240 funds tracked by Wall St. Rank held Select Medical as of Q1 2022.

Based on OrbiMed's 13F filing for Q1 2022, filed 16 May 2022.